FdaApplication
ANDA 217193
Identifiers
- fda_app_no: ANDA217193
Properties
| Property | Value |
|---|---|
| applicant_name | INVAGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2024-05-21 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LANREOTIDE ACETATE | LANREOTIDE ACETATE | EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) | SOLUTION;SUBCUTANEOUS |
| LANREOTIDE ACETATE | LANREOTIDE ACETATE | EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) | SOLUTION;SUBCUTANEOUS |
| LANREOTIDE ACETATE | LANREOTIDE ACETATE | EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) | SOLUTION;SUBCUTANEOUS |
3 products